Abstract
To examine the trend of cardiovascular diseases (CVD) risk factors among a Middle Eastern population with prevalent CVD during a median follow up of 12 years. Patients with prevalent CVD (n = 282, men = 167), with a mean age of 60.76 years were evaluated in four study phases of the TLGS (Tehran lipid glucose study), 2002-2005, 2005-2008, 2008-2011, and 2011-2014. Trends of CVD risk factors were estimated using generalized estimation equation (GEE) models, by adjusting for gender, age and propensity scores. The adjusted prevalence of general and central adiposity, diabetes and physical inactivity at baseline was 25.18, 60.14, 25.03 and 43.74%, respectively and had increasing trends during the study period, reaching 41.32, 66.74, 43.20 and 50.32%, respectively, at the last visit. Although systolic, but not diastolic blood pressure, decreased from 134.88 to 129.86 mmHg, the prevalence of hypertension did not decrease (64.21% vs 68%, p value = 0.326). The prevalence of low high density lipoprotein cholesterol (HDL-C), hypertriglyceridemia and high non-HDL-C at baseline was 74.54, 59.89 and 96.53%, respectively, and showed improved trends reaching 44.87, 47.12 and 96.06% respectively; however, the favorable trend was not observed fo...Continue Reading
References
Jan 12, 2002·BMJ : British Medical Journal·UNKNOWN Antithrombotic Trialists' Collaboration
Nov 7, 2002·American Journal of Epidemiology·Donna K ArnettRussell V Luepker
Aug 21, 2003·JAMA : the Journal of the American Medical Association·Umesh N KhotEric J Topol
Jul 21, 2004·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Daniel E WeinerMark J Sarnak
Oct 27, 2004·Expert Review of Cardiovascular Therapy·Angie Veverka, Jamie L Jolly
Apr 7, 2006·American Journal of Epidemiology·Paul MuntnerPaul K Whelton
Aug 22, 2006·Lancet·Abel Romero-CorralFrancisco Lopez-Jimenez
Mar 3, 2007·Clinical Chemistry·Andrew S LeveyUNKNOWN Chronic Kidney Disease Epidemiology Collaboration
Sep 4, 2007·Lancet·Lars H Lindholm, Shanthi Mendis
Dec 8, 2007·Lancet·Stephen S LimAnthony Rodgers
Feb 2, 2008·Obesity·Antigone OreopoulosKamyar Kalantar-Zadeh
Jan 27, 2009·Trials·Fereidoun AziziUNKNOWN Tehran Lipid and Glucose Study Group
Apr 29, 2009·European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology·Bahareh MotlaghSalim Yusuf
Jun 2, 2009·Lancet·UNKNOWN Antithrombotic Trialists' (ATT) CollaborationAlberto Zanchetti
Sep 16, 2009·International Journal of Obesity : Journal of the International Association for the Study of Obesity·F HadaeghF Azizi
Sep 22, 2009·American Journal of Preventive Medicine·Vicki S ConnSally L Lusk
Mar 10, 2010·Journal of Internal Medicine·K SzummerUNKNOWN SWEDEHEART
May 22, 2010·Lipids in Health and Disease·Yunqin ChenHaozhu Chen
Dec 7, 2010·Cardiovascular Diabetology·Farzad HadaeghFereidoun Azizi
Mar 3, 2011·JAMA : the Journal of the American Medical Association·Angela M ThompsonLydia A Bazzano
Nov 5, 2011·Circulation·Sidney C SmithUNKNOWN World Heart Federation and the Preventive Cardiovascular Nurses Association
Nov 10, 2011·Hypertension·Peter M Nilsson
Oct 3, 2012·PloS One·Maryam TohidiFarzad Hadaegh
Jun 20, 2013·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Lesley A Inker, Andrew S Levey
Jul 31, 2013·American Heart Journal·Usman BaberPaul Muntner
Aug 31, 2013·Stroke; a Journal of Cerebral Circulation·Bruce OvbiageleUNKNOWN PRoFESS Investigators
Nov 14, 2013·Circulation·Neil J StoneUNKNOWN American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Dec 19, 2013·International Journal of Public Health·Jalil KoohpayehzadehAlireza Esteghamati
Jan 25, 2014·Lipids in Health and Disease·Masoumeh KheirandishFarzad Hadaegh
Mar 26, 2014·Nature Reviews. Cardiology·Nathan D Wong
Apr 10, 2014·BMC Public Health·Analice GigliottiRonaldo Laranjeira
Jul 17, 2014·PloS One·Arash DerakhshanFarzad Hadaegh
Aug 21, 2014·Journal of Preventive Medicine and Public Health = Yebang Ŭihakhoe Chi·Moo-Sik LeeAmir Lerman
Nov 5, 2014·British Journal of Clinical Pharmacology·Mary A De VeraDiane Lacaille
Dec 3, 2014·PloS One·Younes Jahangiri-NoudehFarzad Hadaegh
Feb 18, 2015·European Journal of Preventive Cardiology·Kornelia KotsevaUNKNOWN on behalf of the EUROASPIRE Investigators
Apr 12, 2016·Lancet·UNKNOWN NCD Risk Factor Collaboration (NCD-RisC)
May 26, 2016·European Heart Journal·Massimo F PiepoliUNKNOWN ESC Scientific Document Group
Jul 21, 2016·JAMA Cardiology·Stephen SidneyJamal S Rana
Dec 9, 2016·PloS One·Mahsa SardariniaFarzad Hadaegh
Dec 31, 2016·Circulation·Giovanni MariscalcoGavin J Murphy
Jan 11, 2017·Preventive Medicine Reports·Mark Stuntz, Brent Bernstein
Jan 27, 2017·Circulation·Emelia J BenjaminUNKNOWN American Heart Association Statistics Committee and Stroke Statistics Subcommittee
Apr 6, 2017·Physiological Research·H RosolováJ Bruthans
Apr 20, 2017·JAMA Cardiology·Lisandro D ColantonioRobert S Rosenson
Sep 10, 2017·Journal of the American College of Cardiology·Donald M Lloyd-JonesSidney C Smith